Article

Preliminary results promising for intraoperative wavefront measurement of LRI effect

The HD-100, a fourth-generation version of the crystalens accommodating IOL (eyeonics Inc.) provides excellent uncorrected visual acuity (UCVA) at all distances without degrading contrast acuity, according to the results of a U.S. FDA multicenter clinical trial presented by John A. Hovanesian, MD.

Initial experience with intraoperative use of a wavefront analyzer (WaveTec Visions Systems) suggests that it may be a very useful tool for achieving increased accuracy and efficiency in astigmatism correction, said James E. McDonald II, MD.

The device has a very small footprint and attaches to the surgical microscope. Based on Talbot moiré interferometry, it provides real-time analysis of both low and high order aberrations with a resolution of < 0.1 D.

The technology is being evaluated in a multicenter study. Dr. McDonald presented results from a series of 29 patients who underwent cataract surgery with IOL placement and limbal relaxing incisions (LRIs). Wavefront measurements were obtained prior to the phaco incision, after IOL implantation, and after the LRIs. The evaluations added only 1 to 2 minutes to the OR time.

Patients were re-evaluated at 3, 6, and 13 weeks postoperatively, and the analyses showed very strong correlations between the real-time wavefront measurements and the postoperative manifest refractive change and corneal topography.

"In a retrospective review of 191 IOL implantation cases among six surgeons, we found less than 65% of eyes were within 0.5 D of targeted refraction and 1 out of 20 were off by as much 1.0 D. These types of outcomes create a challenge as we present premium lenses to our patients," said Dr. McDonald.

"We are very encouraged by our initial experience with this technology for intraoperative measurements because it suggests it may move us forward toward our goal of better postoperative outcomes."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
© 2025 MJH Life Sciences

All rights reserved.